Interim Results for the half year to 30 April 2026

Progress is real but commercial traction and profitability remain distant and unproven.

What the company is saying

H-Power plc is positioning itself as a first-mover in the UK green hydrogen market, emphasizing its technological leadership and recent commercial milestones. The company highlights the signing of a 5,000kg hydrogen sale agreement with Protium, branding it as the UK's first bulk green hydrogen sale from cracked ammonia, and frames this as a landmark achievement. Management also spotlights a replenishment order from Speedy Hire (15 x LC30 units, subject to CE certification) and a joint development agreement with Komatsu (c.$2m initial contract value) as evidence of growing commercial interest and validation from established industry players. The announcement repeatedly stresses operational progress—such as reduced cash burn, increased capitalised development spend, and a strong cash position—while projecting confidence in meeting near-term certification and delivery targets. However, the company buries or omits granular details on actual revenue from these agreements, the status of key operational milestones (like depot openings or permit variations), and any discussion of profitability or dividend prospects. The tone is upbeat and forward-looking, with management presenting a narrative of momentum and imminent scale-up, but without quantifying the financial impact of most operational claims. Notable individuals such as John Wilson (CEO) and Karl Bostock (CFO) are named, but there is no evidence of external institutional investors or high-profile industry figures directly participating in these deals. This narrative fits a classic early-stage cleantech investor relations strategy: focus on technical breakthroughs, strategic partnerships, and pipeline growth, while deferring hard questions about commercialisation and cash flow. Compared to prior communications (where available), the messaging remains consistent in its optimism and focus on future milestones, with no clear shift in tone or substance.

What the data suggests

The disclosed numbers show a company still in the early stages of commercialisation, with some improvement but a long way to go before financial sustainability. Revenue for the six months to 30 April 2026 was £253,000, a significant increase from £17,000 in the prior comparable period, but still negligible relative to the scale of investment and losses. The loss after tax narrowed to (£5,821,000) from (£10,149,000) in H1 FY25, indicating some operational improvement, but the business remains deeply loss-making. Cash absorbed by operating activities fell to (£7,500,000) from (£10,700,000), and the company ended the period with £17,439,000 in cash, bolstered by expected R&D tax credits of £3,200,000 in H2. Capitalised development costs rose to £13,494,000, reflecting ongoing heavy investment in technology and product development. There is no evidence that prior revenue or profitability targets have been met, and the bulk of the company's financial improvement comes from reduced cash burn and non-operational items (such as inventory write-offs dropping to zero from £2,867,000). The financial disclosures are detailed for headline metrics—revenue, losses, cash, and capitalised costs—but lack project-level or segment breakdowns, making it difficult to assess the commercial impact of individual deals or operational milestones. An independent analyst would conclude that while the company is making progress in reducing losses and cash burn, it remains far from demonstrating a viable, scalable business model. The gap between the company's narrative of commercial momentum and the actual financial evidence is material: most revenue remains aspirational, and the path to profitability is not yet visible in the numbers.

Analysis

The announcement adopts a positive tone, highlighting signed agreements, increased revenue, and reduced cash burn. Several realised milestones are supported by numerical evidence, such as the Protium hydrogen sale agreement, Komatsu JDA, and Speedy Hire orders (albeit subject to CE certification). However, a significant portion of the narrative is forward-looking, including targets for product certification, operational scale-up, and commercial utilisation by late 2026. The capital intensity is high, with substantial capitalised development costs and ongoing R&D spend, while immediate earnings impact remains limited (revenue is still modest relative to losses and investment). Some claims, such as anticipated depot openings and permit variations, lack direct numerical or documentary support. The gap between narrative and evidence is moderate: while progress is real, the language around future scale and market impact is aspirational and not yet underpinned by binding, revenue-generating contracts.

Risk flags

• ●Commercialisation risk: Despite headline agreements, actual revenue remains minimal (£253,000 for H1 FY26), and there is no evidence of recurring or scalable sales. Investors face the risk that signed agreements do not translate into material, repeatable revenue streams.
• ●Execution risk: Key milestones such as CE certification (targeted for August 2026) and delivery of units by year-end are forward-looking and subject to technical, regulatory, and operational hurdles. Any delays could materially impact the company's ability to generate revenue and meet investor expectations.
• ●Capital intensity: The company continues to invest heavily in development, with capitalised development costs rising to £13,494,000 and £4,000,000 spent in H1 FY26 alone. High ongoing investment with limited near-term revenue increases the risk of future dilution or funding shortfalls if commercial traction does not materialise.
• ●Disclosure risk: While headline financials are detailed, there is a lack of transparency around project-level economics, the financial impact of specific deals, and the status of key operational claims (such as depot openings or permit variations). This makes it difficult for investors to assess the true commercial progress.
• ●Forward-looking bias: A significant portion of the announcement is aspirational, with many claims about future sales, utilisation, and cost leadership not yet realised or evidenced. Investors should be cautious about weighting these projections too heavily in their decision-making.
• ●Profitability risk: The company remains deeply loss-making, with a loss after tax of (£5,821,000) in H1 FY26 and no clear path to break-even. Even with reduced cash burn, the current business model is not financially sustainable without a step-change in revenue.
• ●Geographic and regulatory risk: The company operates in a sector subject to evolving regulatory requirements (e.g., CE certification, environmental permits), and any changes or delays in these areas could impact commercial timelines and costs.
• ●Milestone dependency: The narrative and valuation are heavily dependent on achieving near-term milestones (certification, delivery, utilisation targets). Failure to deliver on any of these could undermine investor confidence and the company’s ability to raise further capital.

Bottom line

For investors, this announcement signals incremental operational progress but does not yet provide evidence of a commercially viable or scalable business. The company has succeeded in signing several headline agreements and reducing its cash burn, but revenue remains negligible relative to investment and losses. The narrative is credible in terms of technical and partnership milestones, but the lack of binding, revenue-generating contracts and the absence of project-level financial detail mean that commercial traction is still largely unproven. No notable institutional investors or industry leaders are identified as participating in these deals, so external validation is limited to the named commercial partners. To change this assessment, the company would need to disclose actual unit deliveries, realised revenue from new products, and clear evidence of customer uptake and recurring sales. Key metrics to watch in the next reporting period include revenue growth, progress on CE certification, delivery of LC30 and HY5 units, and any updates on customer utilisation rates. Investors should treat this as a signal to monitor rather than act on immediately: the company is moving in the right direction, but the risk/reward profile remains speculative until commercialisation is proven. The single most important takeaway is that while H-Power is making technical and operational strides, the leap to sustainable, profitable growth is still ahead—and far from guaranteed.

Announcement summary

(AIM: HPOW) H-Power plc announced its interim results for the half year ended 30 April 2026, reporting revenue of £253,000 and a loss after tax of £5,821,000. The company signed a 5,000kg hydrogen sale agreement with Protium, marking the UK's first bulk green hydrogen sale from cracked ammonia, and received a 15 x LC30 replenishment order from Speedy Hire for the Speedy Hydrogen Solutions joint venture, subject to CE certification. Cash at period end was £17,439,000, with £3,200,000 of R&D tax credits expected to be received during H2 FY26. Capitalised development costs increased to £13,494,000, and cash absorbed by operations reduced to £7,500,000 (H1 FY26) from £10,700,000 (H1 FY25). The company also signed a Joint Development Agreement with Komatsu with an initial contract value of approximately $2,000,000. The company projects CE certification of the LC30 unit remains on track for August 2026 and aims to deliver units by calendar year end as operational scale up commences. Management targets Speedy Hydrogen Solutions JV to meet, if not exceed, target utilisation of generators by October 2026.

Disagree with this article?